Literature DB >> 21052094

Modulation of CD4+ T-cell activation by CD95 co-stimulation.

M Paulsen1, S Valentin, B Mathew, S Adam-Klages, U Bertsch, I Lavrik, P H Krammer, D Kabelitz, O Janssen.   

Abstract

CD95 is a dual-function receptor that exerts pro- or antiapoptotic effects depending on the cellular context, the state of activation, the signal threshold and the mode of ligation. In this study, we report that CD95 engagement modulates TCR/CD3-driven signaling pathways in resting T lymphocytes in a dose-dependent manner. While high doses of immobilized CD95 agonists silence T cells, lower concentrations augment activation and proliferation. We analyzed the co-stimulatory capacity of CD95 in detail in resting human CD4(+) T cells, and demonstrate that low-dose ligand-induced co-internalization of CD95 and TCR/CD3 complexes enables non-apoptotic caspase activation, the prolonged activation of MAP kinases, the upregulation of antiapoptotic proteins associated with apoptosis resistance, and the activation of transcription factors and cell-cycle regulators for the induction of proliferation and cytokine production. We propose that the levels of CD95L on antigen-presenting cells (APCs), neighboring T cells or epithelial cells regulate inhibitory or co-stimulatory CD95 signaling, which in turn is crucial for fine-tuning of primary T-cell activation.
© 2011 Macmillan Publishers Limited

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21052094      PMCID: PMC3131913          DOI: 10.1038/cdd.2010.134

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  40 in total

1.  Specific T-cell deletion by transfected human monocytes expressing Fas ligand and antigen.

Authors:  C Cancedda; J LeMaoult; P E Harris; N Suciu-Foca; R Cortesini
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

Review 2.  Internalization and intracellular fate of TCR-CD3 complexes.

Authors:  A Alcover; B Alarcón
Journal:  Crit Rev Immunol       Date:  2000       Impact factor: 2.214

Review 3.  Activation and inhibition of lymphocytes by costimulation.

Authors:  Kenneth A Frauwirth; Craig B Thompson
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

Review 4.  Caspases signal not only apoptosis but also antigen-induced activation in cells of the immune system.

Authors:  Kim Newton; Andreas Strasser
Journal:  Genes Dev       Date:  2003-04-01       Impact factor: 11.361

5.  The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways.

Authors:  T Kataoka; R C Budd; N Holler; M Thome; F Martinon; M Irmler; K Burns; M Hahne; N Kennedy; M Kovacsovics; J Tschopp
Journal:  Curr Biol       Date:  2000-06-01       Impact factor: 10.834

6.  Identification of a lysine-rich region of Fas as a raft nanodomain targeting signal necessary for Fas-mediated cell death.

Authors:  Aurélie Rossin; Rosana Kral; Nadia Lounnas; Krittalak Chakrabandhu; Sébastien Mailfert; Didier Marguet; Anne-Odile Hueber
Journal:  Exp Cell Res       Date:  2010-03-16       Impact factor: 3.905

7.  Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy.

Authors:  M J Raftery; M Schwab; S M Eibert; Y Samstag; H Walczak; G Schönrich
Journal:  Immunity       Date:  2001-12       Impact factor: 31.745

Review 8.  Non-apoptotic Fas signaling.

Authors:  Harald Wajant; Klaus Pfizenmaier; Peter Scheurich
Journal:  Cytokine Growth Factor Rev       Date:  2003-02       Impact factor: 7.638

9.  Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation.

Authors:  H Shinohara; H Yagita; Y Ikawa; N Oyaizu
Journal:  Cancer Res       Date:  2000-03-15       Impact factor: 12.701

10.  Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells.

Authors:  A Alam; L Y Cohen; S Aouad; R P Sékaly
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

View more
  21 in total

1.  Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease.

Authors:  John C Kash; Kathie-Anne Walters; Jason Kindrachuk; David Baxter; Kelsey Scherler; Krisztina B Janosko; Rick D Adams; Andrew S Herbert; Rebekah M James; Spencer W Stonier; Matthew J Memoli; John M Dye; Richard T Davey; Daniel S Chertow; Jeffery K Taubenberger
Journal:  Sci Transl Med       Date:  2017-04-12       Impact factor: 17.956

2.  Dysregulation of the Fas/FasL system in an experimental animal model of HELLP syndrome.

Authors:  Jacob Gibbens; Rachael Morris; Teylor Bowles; Shauna-Kay Spencer; Kedra Wallace
Journal:  Pregnancy Hypertens       Date:  2017-02-24       Impact factor: 2.899

3.  Combination of biological screening in a cellular model of viral latency and virtual screening identifies novel compounds that reactivate HIV-1.

Authors:  Edurne Gallastegui; Brett Marshall; David Vidal; Gonzalo Sanchez-Duffhues; Juan A Collado; Carmen Alvarez-Fernández; Neus Luque; Jean-Michel Terme; Josep M Gatell; Sonsoles Sánchez-Palomino; Eduardo Muñoz; Jordi Mestres; Eric Verdin; Albert Jordan
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

Review 4.  Life in the Fas lane: differential outcomes of Fas signaling.

Authors:  Elizabeth Brint; Grace O'Callaghan; Aileen Houston
Journal:  Cell Mol Life Sci       Date:  2013-04-12       Impact factor: 9.261

Review 5.  The three as: Alternative splicing, alternative polyadenylation and their impact on apoptosis in immune function.

Authors:  Davia Blake; Kristen W Lynch
Journal:  Immunol Rev       Date:  2021-08-08       Impact factor: 12.988

6.  Fas/FasL Signaling Regulates CD8 Expression During Exposure to Self-Antigens.

Authors:  Giovanna Flores-Mendoza; Noé Rodríguez-Rodríguez; Rosa M Rubio; Iris K Madera-Salcedo; Florencia Rosetti; José C Crispín
Journal:  Front Immunol       Date:  2021-03-24       Impact factor: 7.561

7.  Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: reversal by adenoviral vaccine.

Authors:  José Ronnie Vasconcelos; Oscar Bruña-Romero; Adriano F Araújo; Mariana R Dominguez; Jonatan Ersching; Bruna C G de Alencar; Alexandre V Machado; Ricardo T Gazzinelli; Karina R Bortoluci; Gustavo P Amarante-Mendes; Marcela F Lopes; Mauricio M Rodrigues
Journal:  PLoS Pathog       Date:  2012-05-17       Impact factor: 6.823

8.  Low FasL levels promote proliferation of human bone marrow-derived mesenchymal stem cells, higher levels inhibit their differentiation into adipocytes.

Authors:  M R Rippo; L Babini; F Prattichizzo; L Graciotti; G Fulgenzi; F Tomassoni Ardori; F Olivieri; G Borghetti; S Cinti; A Poloni; F Fazioli; A D Procopio
Journal:  Cell Death Dis       Date:  2013-04-18       Impact factor: 8.469

9.  Immunomodulation and T helper TH₁/TH₂ response polarization by CeO₂ and TiO₂ nanoparticles.

Authors:  Brian C Schanen; Soumen Das; Christopher M Reilly; William L Warren; William T Self; Sudipta Seal; Donald R Drake
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240

10.  FcRγ controls the fas-dependent regulatory function of lymphoproliferative double negative T cells.

Authors:  Stephen C Juvet; Christopher W Thomson; Edward Y Kim; Mei Han; Li Zhang
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.